Prawo i regulacje · 08/07/2026

DEA Proposes Scheduling of Tianeptine as Schedule I Controlled Substance

The Drug Enforcement Administration (DEA) proposes moving tianeptine, a prescription medication, from its current classification to Schedule I under the Controlled Substances Act, which would impose strict controls on its handling and distribution. This move would affect individuals and organizations involved in manufacturing, distributing, or possessing tianeptine.